Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
Bladder cancer accounts for nearly 200,000 deaths worldwide yearly. Urothelial carcinoma (UC) accounts for nearly 90% of cases of bladder cancer. Cisplatin-based chemotherapy has remained the mainstay of treatment in the first-line setting for locally advanced or metastatic UC. More recently, the tr...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
MDPI AG
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/26625f45f9874fcfa537b6f572bfa57c |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|